Abstract # 30:

Scheduled for Thursday, June 17, 2010 04:15 PM-04:45 PM: Session 10 (Mezzanine Ballroom A/B/C/D) Oral Presentation


PREVENTATIVE HEALTH AND DISEASES OF THE WOOLLY MONKEY (LAGOTHRIX LAGOTRICHA) AT THE LOUISVILLE ZOO

R. Burns
Louisville Zoological Garden, 1100 Trevilian Way, Louisville, KY 40213, USA
line
     

Louisville Zoo has managed woolly monkeys since the 1970’s. The preventative health program for the species has changed in response to the diseases identified. Woolly monkey hepatitis B virus (HBV) was first described in 1998 from a Louisville Zoo woolly monkey that was diagnosed with fulminant hepatitis. Phylogenetic analysis of the nucleotide sequences indicated that the virus was distinct from the human HBV family and perhaps basal (ancestral) to the human monophyletic group. Study of infected monkeys suggests the virus is not highly pathogenic to most monkeys exposed. Cardiovascular evaluations are included in the preventive health program due to the high incidence of hypertension in woolly monkeys. Years of study have not identified the cause of hypertension in the species. Despite treatment with several drugs used to treat hypertension in other species and evaluation of the diet, an effective control for hypertension in woolly monkeys has not been identified. Diseases secondary to hypertension in woolly monkeys are similar to those in humans, including hypertrophic cardiomyopathy, arteriosclerosis, nephrosclerosis, thromboembolism, and pericardial effusion. Other diseases identified in the species include toxoplasmosis, dental disease, and endoparasitism.